These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2179788)

  • 41. Use of medroxyprogesterone acetate to prevent menopausal symptoms.
    Bullock JL; Massey FM; Gambrell RD
    Obstet Gynecol; 1975 Aug; 46(2):165-8. PubMed ID: 1153148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Initial 17beta-estradiol dose for treating vasomotor symptoms.
    Notelovitz M; Lenihan JP; McDermott M; Kerber IJ; Nanavati N; Arce J
    Obstet Gynecol; 2000 May; 95(5):726-31. PubMed ID: 10775738
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vasomotor flushes and the release of peripheral immunoreactive luteinizing hormone-releasing hormone in postmenopausal women.
    Ravnikar V; Elkind-Hirsch K; Schiff I; Ryan KJ; Tulchinsky D
    Fertil Steril; 1984 Jun; 41(6):881-7. PubMed ID: 6373383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The physiology and measurement of hot flushes.
    Rebar RW; Spitzer IB
    Am J Obstet Gynecol; 1987 May; 156(5):1284-8. PubMed ID: 3578449
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence that GnRH decreases with gonadal steroid feedback but increases with age in postmenopausal women.
    Gill S; Sharpless JL; Rado K; Hall JE
    J Clin Endocrinol Metab; 2002 May; 87(5):2290-6. PubMed ID: 11994378
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.
    Buckler H; Al-Azzawi F;
    BJOG; 2003 Aug; 110(8):753-9. PubMed ID: 12892687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Climacteric syndrome].
    Imthurn B; Maurer-Major E
    Ther Umsch; 2000 Oct; 57(10):595-9. PubMed ID: 11081369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of the dopamine antagonist veralipride on hot flushes and luteinizing hormone secretion in postmenopausal women.
    Melis GB; Gambacciani M; Cagnacci A; Paoletti AM; Mais V; Fioretti P
    Obstet Gynecol; 1988 Nov; 72(5):688-92. PubMed ID: 3140150
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physiological estrogen replacement may enhance the effectiveness of the gonadotropin-releasing hormone agonist in the treatment of hirsutism.
    Carmina E; Janni A; Lobo RA
    J Clin Endocrinol Metab; 1994 Jan; 78(1):126-30. PubMed ID: 8288696
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment of climacteric syndrome using Estraderm TTS and premarin in a comparative study].
    Leodolter S; Sainz H; Moll-Schüler I; Mach R
    Gynakol Geburtshilfliche Rundsch; 1992; 32(4):201-4. PubMed ID: 1337708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy on climacteric symptoms of a new estradiol transdermal patch with active matrix in comparison with a reference reservoir patch. Two long-term randomized multicenter parallel-group studies.
    Rovati LC; Schmid K; Giacovelli G; Bonn M; Setnikar I; Wolff F; Genazzani AR
    Arzneimittelforschung; 1999 Nov; 49(11):933-43. PubMed ID: 10604047
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quality of life after the menopause: influence of hormonal replacement therapy.
    Limouzin-Lamothe MA; Mairon N; Joyce CR; Le Gal M
    Am J Obstet Gynecol; 1994 Feb; 170(2):618-24. PubMed ID: 7509570
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of transdermal estradiol on hormone and metabolic dynamics over a six-week period.
    Haas S; Walsh B; Evans S; Krache M; Ravnikar V; Schiff I
    Obstet Gynecol; 1988 May; 71(5):671-6. PubMed ID: 3357653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women.
    Guthrie JR; Dennerstein L; Hopper JL; Burger HG
    Obstet Gynecol; 1996 Sep; 88(3):437-42. PubMed ID: 8752255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of hot flashes in premenopausal women treated with a long-acting GnRH agonist.
    DeFazio J; Meldrum DR; Laufer L; Vale W; Rivier J; Lu JK; Judd HL
    J Clin Endocrinol Metab; 1983 Mar; 56(3):445-8. PubMed ID: 6401756
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sex steroid control of gonadotropin secretion in the human male. II. Effects of estradiol administration in normal and gonadotropin-releasing hormone-deficient men.
    Finkelstein JS; O'Dea LS; Whitcomb RW; Crowley WF
    J Clin Endocrinol Metab; 1991 Sep; 73(3):621-8. PubMed ID: 1908485
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of oral medroxyprogesterone acetate on menopausal symptoms in patients with endometrial carcinoma.
    Aslaksen K; Frankendal B
    Acta Obstet Gynecol Scand; 1982; 61(5):423-8. PubMed ID: 6760653
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Percutaneous 17beta-estradiol gel for the treatment of vasomotor symptoms in postmenopausal women.
    Archer DF;
    Menopause; 2003; 10(6):516-21. PubMed ID: 14627859
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
    J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women.
    Lin SQ; Sun LZ; Lin JF; Yang X; Zhang LJ; Qiao J; Wang ZH; Xu YX; Xiong ZA; Zhou YZ; Wang ML; Zhu J; Chen SR; Su H; Yang CS; Wang SH; Zhang YZ; Dong XJ
    Climacteric; 2011 Aug; 14(4):472-81. PubMed ID: 21469973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.